Q2 2017 Holdings
Filed 2017-08-14 | 15 holdings | $3.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anavex Life Sciences Corp(AVXL) | COM NEW | 032797300 | $3.9M | 724,205 | 98.2% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $23.6K | 3,738,925 | 0.6% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $20.2K | 807,224 | 0.5% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $15.1K | 2,359,767 | 0.4% |
| Vascular Biogenics LTD | COM | M96883109 | $3.8K | 860,605 | 0.1% |
| Volition RX LTD(VNRX) | COM | 928661107 | $1.6K | 461,538 | 0.0% |
| Keryx Biopharmaceuticals Inc. | COM | 492515101 | $1.4K | 200,000 | 0.0% |
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | $1.4K | 2,595,484 | 0.0% |
| Alcobra Ltd | SHS | M2239P109 | $1.4K | 1,205,498 | 0.0% |
| Summit Therapeutics PLC | SPONS ADS | 86627R102 | $1.1K | 100,000 | 0.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $583 | 124,096 | 0.0% |
| Caladrius Biosciences Inc(NBSEUR) | COM NEW | 128058203 | $549 | 117,957 | 0.0% |
| Evoke Pharma Inc | COM | 30049G104 | $448 | 175,000 | 0.0% |
| Advaxis Inc. | W EXP 07/15/201 | 007624117 | $368 | 112,500 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $101 | 25,000 | 0.0% |